When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PTN - Palatin Tech puts end to Vyleesi license agreement with Amag Pharma
Palatin Technologies Inc.
Palatin Technologies (NYSEMKT:PTN)jumps 10% premarket after terminating January 2017 license agreement with AMAG Pharmaceuticals (NASDAQ:AMAG), which granted latter exclusive rights to develop and commercialize Vyleesi (bremelanotide), a melanocortin receptor agonist indicated for the treatment of generalized hypoactive sexual desire disorder in premenopausal women, in North America.
More news on: Palatin Technologies, Inc., AMAG Pharmaceuticals, Inc., Healthcare stocks news,